HIV associated nephropathy screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{HIV associated nephropathy}} | {{HIV associated nephropathy}} | ||
{{CMG}}{{APM}};{{AE}}{{KW}} | {{CMG}}{{APM}};{{AE}} {{SHA}} {{KW}} | ||
==Overview== | ==Overview== | ||
Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection). | [[Screening (medicine)|Screening]] for kidney disease is recommended in high risk populations in all patients with seropositive [[Human Immunodeficiency Virus (HIV)|HIV-1]] (upon detection).<ref name="pmid29872351" /> | ||
==Screening== | ==Screening== | ||
Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection). | [[Screening (medicine)|Screening]] for kidney disease is recommended in high risk populations in all patients with seropositive [[Human Immunodeficiency Virus (HIV)|HIV-1]] (upon detection).<ref name="pmid29872351">{{cite journal| author=Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA | display-authors=etal| title=HIV-associated nephropathy: links, risks and management. | journal=HIV AIDS (Auckl) | year= 2018 | volume= 10 | issue= | pages= 73-81 | pmid=29872351 | doi=10.2147/HIV.S141978 | pmc=5975615 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29872351 }} </ref> | ||
=== HIV screening === | |||
* According to the U.S. Preventive Service Task Force, clinicians should screen for HIV in: | |||
** Adolescents and adults ages 15 to 65 | |||
** Pregnant Persons | |||
* Center of Disease Control (CDC) recommendations for HIV [[Screening (medicine)|screening]]: | |||
** People between the ages of 13 and 64 should get tested for HIV at least once. | |||
** Those with [[Risk factor|risk factors]] for HIV are recommended to be screened more frequently. The CDC suggests that people with risk factors should be tested at least once a year. | |||
** Asymptomatic sexually active men who have sex with men (MSM) should be screened once a year. The benefits of more frequent screening ( once every 3 or 6 months) for MSM at increased risk for HIV infection should be considered. | |||
* | |||
* | * | ||
* | * | ||
* | * | ||
* | |||
==References== | ==References== | ||
Latest revision as of 19:22, 30 June 2020
|
HIV associated nephropathy Microchapters |
|
Differentiating HIV associated nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV associated nephropathy screening On the Web |
|
American Roentgen Ray Society Images of HIV associated nephropathy screening |
|
Risk calculators and risk factors for HIV associated nephropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[3] Krzysztof Wierzbicki M.D. [4]
Overview
Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection).[1]
Screening
Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection).[1]
HIV screening
- According to the U.S. Preventive Service Task Force, clinicians should screen for HIV in:
- Adolescents and adults ages 15 to 65
- Pregnant Persons
- Center of Disease Control (CDC) recommendations for HIV screening:
- People between the ages of 13 and 64 should get tested for HIV at least once.
- Those with risk factors for HIV are recommended to be screened more frequently. The CDC suggests that people with risk factors should be tested at least once a year.
- Asymptomatic sexually active men who have sex with men (MSM) should be screened once a year. The benefits of more frequent screening ( once every 3 or 6 months) for MSM at increased risk for HIV infection should be considered.
References
- ↑ 1.0 1.1 Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA; et al. (2018). "HIV-associated nephropathy: links, risks and management". HIV AIDS (Auckl). 10: 73–81. doi:10.2147/HIV.S141978. PMC 5975615. PMID 29872351.